SKC announces EUCOPE membership

European Confederation of Pharmaceutical Entrepreneurs

Mon, 2022 / 11 / 14
SKC is member of EUCOPE, the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), Europe's trade body for small and mid-sized innovative companies working in the field of biopharmaceuticals and medical technologies.

With more than 2600 members, EUCOPE represents innovative companies that are researching, designing, developing, supplying, manufacturing, and deploying the next generation of pharmaceutical innovation and therapeutic solutions in Europe.

The EUCOPE team provides expert insights in legal, public policy and government affairs. In close collaboration with their members, EUCOPE analyses, monitors and engages several topics and themes in its working groups, steering groups, task forces and partner networks. SKC will be especially involved in the following areas in the future:

  • Orphan Medicinal Products Working Group
  • P&R/Markect Access Working Group
  • Genomics Working Group
  • EU HTA Regulation Task Force
  • Cell & Gene Therapy Working Group
  • Digital Health Working Group

Find more informationen about EUCOPE at https://www.eucope.org/

About the author

Ihre Ansprechpartnerin  Karolin Priese
Karolin Priese
Dipl.-Kauffrau
Fon: +49 511 64 68 14 – 0
Fax: +49 511 64 68 14 18

EU HTA: European Health Technology Assessment (JCA)


Achieve planning security: With us you can align your projects and your resource planning comprehensively and at an early stage on EU HTA and its implications for market access.

Pharma & Biotech


SKC is the partner of choice for German market access and the AMNOG process.
to the top